Wondering if Teleflex is a beaten down opportunity or a value trap at today’s price? Let us walk through what the numbers are really saying about the stock. After sliding 3.8% over the last week, ...
10d
Teleflex (TFX): Reassessing Valuation After Recent Share Price Pullback and Mixed Long-Term Returns
Teleflex (TFX) has quietly become a talking point after another choppy week for medtech names, with the stock drifting lower over the past week even as the past month’s performance turned positive.
Zacks Investment Research on MSN
Should you retain Teleflex stock in your portfolio now?
Teleflex’s TFX Interventional Urology portfolio is well positioned for sustained growth, led by UroLift’s expanding global footprint and strong clinical differentiation. Supported by favorable ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Founded in 1943, the company has ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Teleflex Inc. announced that it has entered into definitive agreements to sell its OEM business as well as its acute care and interventional urology divisions to two different buyers. Intersurgical ...
Dec 9 (Reuters) - Medical device maker Teleflex (TFX.N), opens new tab said on Tuesday it would sell three units for a combined $2.03 billion, as it sharpens its focus on its critical care and ...
After announcing plans to split up the company near the top of this year, Teleflex said it has found new homes for its businesses spanning acute care, urology and medical hardware manufacturing. Two ...
Private equity firms Montagu and Kohlberg have announced plans to acquire Wayne, PA-based OEM Teleflex Medical for $1.5 billion in a carve-out transaction. Teleflex Medical OEM, which has been in ...
On Tuesday, 18 November 2025, Teleflex Incorporated (NYSE:TFX) presented at the Jefferies London Healthcare Conference 2025, outlining its strategic plans for restructuring. The company is focusing on ...
Teleflex Incorporated (NYSE:TFX) reported better-than-expected earnings for the third quarter on Thursday. The company posted quarterly earnings of $3.67 per share which beat the analyst consensus ...
Medical technology company Teleflex (NYSE:TFX) reported Q3 CY2025 results topping the market’s revenue expectations , with sales up 19.4% year on year to $913 million. Its non-GAAP profit of $3.67 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback